PubMed=30995489; DOI=10.1016/j.celrep.2019.03.047
MacLeod G., Bozek D.A., Rajakulendran N., Monteiro V., Ahmadi M., Steinhart Z., Kushida M.M., Yu H., Coutinho F.J., Cavalli F.M.G., Restall I.J., Hao X.-G., Hart T., Luchman H.A., Weiss S., Dirks P.B., Angers S.
Genome-wide CRISPR-Cas9 screens expose genetic vulnerabilities and mechanisms of temozolomide sensitivity in glioblastoma stem cells.
Cell Rep. 27:971-986.e9(2019)

DOI=10.1021/acsmaterialsau.3c00029
Smith L.J., Skirzynska A., Chin A.A., Arnold A.E., Kushida M.M., Dirks P.B., Shoichet M.S.
Engineered in vitro tumor model recapitulates molecular signatures of invasion in glioblastoma.
ACS Materials Au 3:514-527(2023)